Avoid Harsh Products: We recommend our patients stop using harsh skincare products, including exfoliants or harsh cleansers, right after the treatment
FDA Releases Guidance for Compounding Pharmacies
A small number of GHR antagonists have been used in an oncology settings in preclinical studies and the growth-inhibiting effects have been reported in colon, breast, and meningioma tumor xenografts, which suggested that GHR antagonism as a monotherapy is efficient in some tumor types (Friend, 2001
CoolSculpting CoolSculpting offers a revolutionary breakthrough in the world of noninvasive aesthetic medicine
Salehi B, Mishra AP, Nigam M, Sener B, Kilic M, Sharifi-Rad M, et al